Constitutively	O
nuclear	B-Cellular_component
FOXO3a	O
localization	O
predicts	O
poor	O
survival	O
and	O
promotes	O
Akt	O
phosphorylation	O
in	O
breast	B-Cancer
cancer	I-Cancer
.	O

BACKGROUND	O
:	O
The	O
PI3K	O
-	O
Akt	O
signal	O
pathway	O
plays	O
a	O
key	O
role	O
in	O
tumorigenesis	O
and	O
the	O
development	O
of	O
drug	O
-	O
resistance	O
.	O

Cytotoxic	O
chemotherapy	O
resistance	O
is	O
linked	O
to	O
limited	O
therapeutic	O
options	O
and	O
poor	O
prognosis	O
.	O

METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Examination	O
of	O
FOXO3a	O
and	O
phosphorylated	O
-	O
Akt	O
(	O
P	O
-	O
Akt	O
)	O
expression	O
in	O
breast	B-Cancer
cancer	I-Cancer
tissue	I-Cancer
microarrays	O
showed	O
nuclear	B-Cellular_component
FOXO3a	O
was	O
associated	O
with	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
positivity	O
(	O
p	O
=	O
0	O
.	O
052	O
)	O
,	O
poor	O
prognosis	O
(	O
p	O
=	O
0	O
.	O
014	O
)	O
,	O
and	O
P	O
-	O
Akt	O
expression	O
in	O
invasive	B-Cancer
ductal	I-Cancer
carcinoma	I-Cancer
.	O

Using	O
tamoxifen	O
and	O
doxorubicin	O
-	O
sensitive	O
and	O
-	O
resistant	O
breast	B-Cell
cancer	I-Cell
cell	I-Cell
lines	I-Cell
as	O
models	O
,	O
we	O
found	O
that	O
doxorubicin	O
-	O
but	O
not	O
tamoxifen	O
-	O
resistance	O
is	O
associated	O
with	O
nuclear	B-Cellular_component
accumulation	O
of	O
FOXO3a	O
,	O
consistent	O
with	O
the	O
finding	O
that	O
sustained	O
nuclear	B-Cellular_component
FOXO3a	O
is	O
associated	O
with	O
poor	O
prognosis	O
.	O

We	O
also	O
established	O
that	O
doxorubicin	O
treatment	O
induces	O
proliferation	O
arrest	O
and	O
FOXO3a	O
nuclear	B-Cellular_component
relocation	O
in	O
sensitive	O
breast	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

Induction	O
of	O
FOXO3a	O
activity	O
in	O
doxorubicin	O
-	O
sensitive	O
MCF	B-Cell
-	I-Cell
7	I-Cell
cells	I-Cell
was	O
sufficient	O
to	O
promote	O
Akt	O
phosphorylation	O
and	O
arrest	O
cell	B-Cell
proliferation	O
.	O

Conversely	O
,	O
knockdown	O
of	O
endogenous	O
FOXO3a	O
expression	O
reduced	O
PI3K	O
/	O
Akt	O
activity	O
.	O

Using	O
MDA	B-Cell
-	I-Cell
MB	I-Cell
-	I-Cell
231	I-Cell
cells	I-Cell
,	O
in	O
which	O
FOXO3a	O
activity	O
can	O
be	O
induced	O
by	O
4	O
-	O
hydroxytamoxifen	O
,	O
we	O
showed	O
that	O
FOXO3a	O
induction	O
up	O
-	O
regulates	O
PI3K	O
-	O
Akt	O
activity	O
and	O
enhanced	O
doxorubicin	O
resistance	O
.	O

However	O
FOXO3a	O
induction	O
has	O
little	O
effect	O
on	O
cell	B-Cell
proliferation	O
,	O
indicating	O
that	O
FOXO3a	O
or	O
its	O
downstream	O
activity	O
is	O
deregulated	O
in	O
the	O
cytotoxic	O
drug	O
resistant	O
breast	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

Thus	O
,	O
our	O
results	O
suggest	O
that	O
sustained	O
FOXO3a	O
activation	O
can	O
enhance	O
hyperactivation	O
of	O
the	O
PI3K	O
/	O
Akt	O
pathway	O
.	O

CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
Together	O
these	O
data	O
suggest	O
that	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
and	O
poor	O
survival	O
in	O
invasive	B-Cancer
ductal	I-Cancer
breast	I-Cancer
carcinoma	I-Cancer
are	O
linked	O
to	O
an	O
uncoupling	O
of	O
the	O
Akt	O
-	O
FOXO3a	O
signaling	O
axis	O
.	O

In	O
these	O
breast	B-Cancer
cancers	I-Cancer
activated	O
Akt	O
fails	O
to	O
inactivate	O
and	O
re	O
-	O
localize	O
FOXO3a	O
to	O
the	O
cytoplasm	B-Organism_substance
,	O
and	O
nuclear	B-Cellular_component
-	O
targeted	O
FOXO3a	O
does	O
not	O
induce	O
cell	B-Cell
death	O
or	O
cell	B-Cell
cycle	O
arrest	O
.	O

As	O
such	O
,	O
sustained	O
nuclear	B-Cellular_component
FOXO3a	O
expression	O
in	O
breast	B-Cancer
cancer	I-Cancer
may	O
culminate	O
in	O
cancer	B-Cancer
progression	O
and	O
the	O
development	O
of	O
an	O
aggressive	O
phenotype	O
similar	O
to	O
that	O
observed	O
in	O
cytotoxic	O
chemotherapy	O
resistant	O
breast	B-Cell
cancer	I-Cell
cell	I-Cell
models	O
.	O

